IQVIA Holdings Inc (IQV)vsPersonalis Inc (PSNL)
IQV
IQVIA Holdings Inc
$165.64
-0.27%
HEALTHCARE · Cap: $28.11B
PSNL
Personalis Inc
$7.78
+2.23%
HEALTHCARE · Cap: $796.25M
Smart Verdict
WallStSmart Research — data-driven comparison
IQVIA Holdings Inc generates 23318% more annual revenue ($16.31B vs $69.65M). IQV leads profitability with a 8.3% profit margin vs -116.7%. IQV earns a higher WallStSmart Score of 72/100 (B).
IQV
Strong Buy72
out of 100
Grade: B
PSNL
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+49.1%
Fair Value
$348.46
Current Price
$165.64
$182.82 discount
Intrinsic value data unavailable for PSNL.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 21 in profit
Growing faster than its price suggests
Earnings expanding 23.6% YoY
No standout strengths identified
Areas to Watch
Distress zone — elevated risk
3.2% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -35.0% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : IQV
The strongest argument for IQV centers on Return on Equity, PEG Ratio, EPS Growth. Revenue growth of 10.3% demonstrates continued momentum. PEG of 0.97 suggests the stock is reasonably priced for its growth.
Bull Case : PSNL
PSNL has a balanced fundamental profile.
Bear Case : IQV
The primary concerns for IQV are Altman Z-Score.
Bear Case : PSNL
The primary concerns for PSNL are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
IQV profiles as a value stock while PSNL is a turnaround play — different risk/reward profiles.
PSNL carries more volatility with a beta of 2.11 — expect wider price swings.
IQV is growing revenue faster at 10.3% — sustainability is the question.
IQV generates stronger free cash flow (561M), providing more financial flexibility.
Bottom Line
IQV scores higher overall (72/100 vs 24/100) and 10.3% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
IQVIA Holdings Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.
Personalis Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?